Get the Stockscreener App
2.52
7.35%
-0.20
Pre-market:
2.46
-0.06
-2.38%
Anebulo Pharmaceuticals Inc stock is traded at $2.52, with a volume of 23,351.
It is down -7.35% in the last 24 hours and up +1.20% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
See More
Previous Close:
$2.72
Open:
$2.71
24h Volume:
23,351
Relative Volume:
0.17
Market Cap:
$103.53M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-8.40
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
+8.15%
1M Performance:
+1.20%
6M Performance:
+142.31%
1Y Performance:
+33.33%
1-Day Range:
$2.52
$2.7376
1-Week Range:
$2.26
$2.7376
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.52 | 101.07M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flows2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
What is the fair value of Anebulo Pharmaceuticals Inc. stock nowPortfolio Return Summary & Expert-Curated Trade Recommendations - newser.com
Is Anebulo Pharmaceuticals Inc. stock resilient to inflationEarnings Trend Report & Verified Short-Term Trading Plans - newser.com
Advanced analytics toolkit walkthrough for Anebulo Pharmaceuticals Inc.Trade Entry Summary & Precise Buy Zone Identification - newser.com
Why Anebulo Pharmaceuticals Inc. stock could see breakout soon2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
What technical charts say about Anebulo Pharmaceuticals Inc. stock2025 Market Outlook & Weekly High Momentum Picks - newser.com
Tick level data insight on Anebulo Pharmaceuticals Inc. volatilityEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Anebulo Pharmaceuticals Inc. outperform the marketFed Meeting & Risk Managed Investment Strategies - newser.com
Will Anebulo Pharmaceuticals Inc. price bounce be sustainablePrice Action & Reliable Price Breakout Signals - newser.com
Published on: 2025-10-13 07:20:43 - newser.com
Price action breakdown for Anebulo Pharmaceuticals Inc.M&A Rumor & Real-Time Volume Trigger Notifications - newser.com
Measuring Anebulo Pharmaceuticals Inc.’s beta against major indices2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Anebulo approves reverse stock split ahead of going-private transaction - MSN
Is Anebulo Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Breakouts & Capital Protection Trading Alerts - newser.com
Does Anebulo Pharmaceuticals Inc. qualify in momentum factor screeningEarnings Miss & High Return Trade Opportunity Guides - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Anebulo Pharmaceuticals (NASDAQ:ANEB) - MarketBeat
What drives Anebulo Pharmaceuticals Inc stock priceHigh Beta Stocks & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Can Anebulo Pharmaceuticals Inc. recover in the next quarterJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Anebulo Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
Regression analysis insights on Anebulo Pharmaceuticals Inc. performanceSell Signal & Smart Allocation Stock Tips - newser.com
What institutional flow reveals about Anebulo Pharmaceuticals Inc.Trade Risk Report & Capital Efficiency Focused Ideas - newser.com
Can Anebulo Pharmaceuticals Inc. stock attract ESG capital inflowsPrice Action & Stock Market Timing Techniques - newser.com
Can Anebulo Pharmaceuticals Inc. stock continue upward trendWeekly Market Summary & Comprehensive Market Scan Insights - newser.com
We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - Yahoo Finance
Visualizing Anebulo Pharmaceuticals Inc. stock with heatmapsGap Down & Fast Entry and Exit Trade Plans - newser.com
Will breakout in Anebulo Pharmaceuticals Inc. lead to full recoveryJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Does Anebulo Pharmaceuticals Inc. fit your quant trading model2025 EndofYear Setup & Community Consensus Trade Alerts - newser.com
Goldman Sachs Group Inc. Invests $62,000 in Anebulo Pharmaceuticals, Inc. $ANEB - Defense World
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.96%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):